Fundraising FoxCivilization Ventures Management, Llc — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Yusuf Erkul(Founder)inJeff Ozdemir(Founder)inBurak Yilmaz(Founder)inCatherine Moroski(Executive Officer, Director)inOguzhan Yilmas(Director)Burak YILMAZ(Founder)in
Co-investorsAmino CollectiveAsymmetry VenturesFoundersX VenturesGaingelsHOF CapitalHummingbird Ventures+13 more
__Twitter.png)
Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy.
AI & Machine LearningBiotechDeep TechBoston, US
Shashi Murthy(Executive Officer)inSean Kevlahan(Co-founder & CEO)inThomas Neenan(Co-founder & CBO)in
Co-investorsBantam Group
TenSixty uses machine learning and cell biology expertise to identify novel antibody targets on cancer cells for the development of new cancer therapeutics.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Daniel Montoro(Chief Executive Officer)inKarthik Jagadeesh(Chief AI Officer)Christoph Muus(Chief Technology Officer)
BoardDipchand Nishar(Director)Sara Choi(Director)in
Co-investorsGeneral CatalystWingThe Engine Ventures
.png)
uLab Systems builds digital orthodontics tools, including software (uDesign, uAssist) and uSmile clear aligners manufactured in the USA, for dental professionals and orthodontic practices.
BiotechDigital HealthHealthtechMedical DevicesSaaSMemphis, US
AmirAli Talasaz(Director)Mark Foley(Director)David Thrower(Executive Officer)Tim Dumore(Director)Rita O'Connor(Director)Robert Doty(Executive Officer)
Co-investors7 Gate VenturesAPERTURE Venture PartnersTachles VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.